Hims AI Visibility Market Strategy Report - Hair Loss Treatments

Answer Capsule

Hims holds 53.41% valid recommendation coverage in the October 2026 Hair Loss Treatments benchmark, third behind Rogaine at 59.28% and Nutrafol at 55.11%. The brand is visible in 71.78% of qualified observations and converts that presence into top-three placement at a 51.33% rate, the highest top-three rate in the category. Its clearest weakness is rank-one conversion: Hims holds first position in only 20.64% of qualified observations while Rogaine holds 41.10%. The clearest opportunity sits in Google AI Overviews, where Hims already reaches 78.18% valid recommendation coverage and 26.06% rank-one placement, the strongest single-platform position in the tracked set.

Who This Report Is For

This report is written for Hims marketing, brand, and growth leadership, and for category analysts tracking how AI systems recommend hair loss treatments at the discovery and consideration stage.

Report Card

Executive Summary

Hims enters October 2026 as the category's strongest top-three performer and its third-strongest brand by valid recommendation coverage. The benchmark recorded 282 valid recommendations for Hims across 528 qualified observations, a coverage rate of 53.41%. That places the brand 5.87 percentage points behind category leader Rogaine and 1.70 points behind Nutrafol.

The gap between presence and recommendation is narrow for Hims. Raw mention presence reached 71.78%, and valid recommendation coverage reached 53.41%, meaning roughly three of every four appearances convert into a recommendation that meets benchmark criteria. That conversion ratio is stronger than Nutrafol's, which holds 67.23% presence against 55.11% coverage.

The strongest cluster signal is unambiguous. All 528 qualified observations fell into the Brand Recommendation class, covering discovery and consideration intent for hair loss treatments. Hims holds 271 top-three placements and 109 rank-one placements in that cluster, with an average recommended rank of 1.71, the second-best average position in the tracked set behind Rogaine's 1.58.

The weakest cluster signal is structural rather than competitive. The benchmark produced no qualified observations in the Pricing & Value or Multi-Brand Comparison classes in October 2026, so the public series cannot yet show how Hims performs when buyers ask cost or head-to-head questions. That is a measurement gap, not a performance finding.

The strongest platform signal for Hims is Google AI Overviews. The brand reached 78.18% valid recommendation coverage there, with 129 valid recommendations, a 76.97% top-three rate, and a 26.06% rank-one rate. That is the highest coverage Hims holds on any tracked platform and the highest single-platform coverage figure in the category.

The clearest platform gap is ChatGPT. Hims holds 25.00% valid recommendation coverage there across 12 observations, with 3 valid recommendations and a 41.67% raw mention presence rate. The sample is small, but the direction is consistent with a platform where the brand is mentioned without being recommended at the same rate it is elsewhere.

Sentiment framing is positive across the board. Hims recorded 285 positive mentions, 94 neutral mentions, and zero negative mentions, producing a net sentiment score of 0.7520. No platform in the tracked set recorded a negative mention for the brand.

What Hims Is Winning

Questions This Section Answers

• Why does Hims hold the highest top-three recommendation rate in the Hair Loss Treatments category?
• How does Google AI Overviews contribute to Hims's strongest platform position?
• What source-footprint advantage does Hims hold in the benchmark's cited domains?

Hims holds the highest top-three recommendation rate in the Hair Loss Treatments category at 51.33%. Rogaine sits at 51.14% and Nutrafol at 36.74%. That means when AI systems build a shortlist of hair loss treatment options, Hims appears in the top three more often than any other tracked brand.

The brand also holds the second-best average recommended rank in the category at 1.71, behind Rogaine at 1.58 and ahead of every other tracked brand. When Hims earns rank credit, it earns it near the top of the answer.

Google AI Overviews is the clearest platform win. Hims reached 78.18% valid recommendation coverage there, with 129 valid recommendations from 165 observations. The brand also holds a 26.06% rank-one rate on that platform, meaning it is the single top recommendation in roughly one of every four AI Overview answers it appears in.

Hims holds the only tracked brand domain in the benchmark's top 10 cited domains. The brand's domain appeared at rank 3 with 283 citations, a 3.8% share of all citations, and was cited by all six tracked AI platforms. That is a source-footprint advantage no other tracked brand in this category holds.

Sentiment framing is clean. Hims recorded zero negative mentions across 379 total mentions in October 2026, with a net sentiment score of 0.7520. The brand is not carrying a cautionary or comparison-anchor framing problem in the qualified set.

Where Hims Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why does Hims convert its category-leading top-three rate into a rank-one rate less than half of Rogaine's?
• Which AI platforms show the weakest recommendation conversion for Hims despite raw mention presence?
• How does Nutrafol's sentiment advantage complicate Hims's standing?

The clearest gap is rank-one conversion. Hims holds a 51.33% top-three rate but only a 20.64% rank-one rate. Rogaine holds a nearly identical top-three rate at 51.14% but converts that into first position at 41.10%. Both brands reach the shortlist at the same rate; Rogaine is chosen first twice as often. That is the single largest displacement pattern in the Hims data.

ChatGPT is the weakest platform signal. Hims holds 25.00% valid recommendation coverage there across 12 observations, with 3 valid recommendations and 1 rank-one placement. The brand's raw mention presence on ChatGPT is 41.67%, meaning it appears in roughly two of every five answers but converts to a valid recommendation in only one of four. The sample is small enough that the benchmark treats it as directional, but the pattern is consistent with a platform where Hims is referenced as context rather than recommended as a choice.

Perplexity shows a similar but less severe pattern. Hims holds 34.88% valid recommendation coverage there across 43 observations, with 15 valid recommendations and a 9.30% rank-one rate. The brand is present in 44.19% of Perplexity answers but converts to a top-three placement at 34.88%, a narrower gap than ChatGPT but still below the brand's category-wide conversion rate.

The mid-tier competitive picture is stable but not comfortable. Nutrafol holds 55.11% coverage against Hims at 53.41%, a 1.70-point gap. Nutrafol also holds a higher net sentiment score at 0.8479 against Hims at 0.7520. The two brands are close enough on coverage that small shifts in either direction would change their relative standing, and Nutrafol currently carries the stronger framing signal.

The benchmark's cluster structure limits what can be diagnosed. All qualified observations fell into the Brand Recommendation class. The Pricing & Value and Multi-Brand Comparison classes produced zero qualified observations in October 2026, so the public series cannot show whether Hims wins or loses when buyers ask cost or head-to-head questions. That is a measurement boundary, not evidence that Hims performs poorly in those prompt types.

Biggest Opportunity

Questions This Section Answers

• Which platforms offer the clearest path to improving Hims's rank-one conversion?
• How can Hims's existing citation footprint be leveraged to close the first-position gap?

The clearest path from reference to recommendation for Hims runs through rank-one conversion on Google AI Overviews and Perplexity. Hims already reaches the shortlist at the highest rate in the category. The gap is first position. On AI Overviews, Hims holds a 76.97% top-three rate but a 26.06% rank-one rate. On Perplexity, the brand holds a 34.88% top-three rate but a 9.30% rank-one rate. Closing even part of that gap on the two platforms where Hims already has strong coverage would move the brand's rank-one rate toward Rogaine's 41.10% without requiring new presence.

The supporting evidence layer points the same direction. Hims holds the only tracked brand domain in the benchmark's top 10 cited domains, cited by all six platforms. The brand's owned pages are already part of the public evidence layer AI systems retrieve from. The opportunity is to make those pages answer the specific comparison and selection questions that currently resolve to Rogaine in first position.

Competitive Landscape

Questions This Section Answers

• Who leads the Hair Loss Treatments category on recommendation-stage metrics?
• How does Hims compare to Rogaine and Nutrafol on top-three rate, rank-one rate, and sentiment?

Rogaine holds the strongest recommendation-stage position in the Hair Loss Treatments category, followed by Nutrafol and Hims. The three brands sit within 5.87 percentage points of each other on valid recommendation coverage, and the tier beneath them drops sharply, with Happy Head at 28.98% and Propecia (Merck) at 22.35%.

Average recommended rank covers rank-eligible recommendations only.

Hims holds the highest top-three rate in the category at 51.33%, narrowly ahead of Rogaine at 51.14%, but converts that placement into first position at less than half Rogaine's rate. Nutrafol sits below Hims on top-three placement by 14.59 points but carries the strongest sentiment framing in the category at 0.8479.

Prompt Evidence

Questions This Section Answers

• Which prompts and platforms show Hims at its strongest and weakest recommendation conversion?
• Where does Hims appear in the top three but fail to convert to rank one?

Google AI Overviews / Best Hair Loss Treatments & Top Solutions Prompt: "What are the top 3 hair growth products?" Result: Hims appeared in the top three at a 76.97% rate on this platform, with 127 top-three placements from 165 observations.

ChatGPT / Best Hair Loss Treatments & Top Solutions Prompt: "hair loss treatment" Result: Hims reached 25.00% valid recommendation coverage across 12 observations, with 3 valid recommendations and 1 rank-one placement, the brand's weakest platform conversion rate.

Perplexity / Best Hair Loss Treatments & Top Solutions Prompt: "What is the most effective hair growth serum?" Result: Hims held a 34.88% top-three rate and a 9.30% rank-one rate across 43 observations, present in 44.19% of answers but converting to first position in fewer than one in ten.

Google AI Mode / Best Hair Loss Treatments & Top Solutions Prompt: "minoxidil for women" Result: Hims reached 39.49% valid recommendation coverage across 157 observations, with 62 valid recommendations and a 19.75% rank-one rate.

What CiteWorks Studio Would Do Next

Phase 1: AI Visibility Market Discovery Audit Map the exact prompts and platform surfaces where Hims reaches the shortlist but loses first position, with priority on Google AI Overviews and Perplexity where coverage is already strong.

Phase 2: Recommendation Readiness Plan Identify which owned pages, product descriptions, and comparison assets need to answer the selection questions that currently resolve to Rogaine in rank one.

Phase 3: Owned Answer Layer Buildout Strengthen the pages AI systems retrieve when building hair loss treatment shortlists, with clear positioning on efficacy, suitability, and treatment format.

Phase 4: Citation / Authority Layer Development Extend the brand's existing citation advantage, already the only tracked brand domain in the benchmark's top 10 cited domains, into the health and medical reference sources that dominate the rest of the citation list.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track rank-one conversion by platform and prompt cluster month over month, with the goal of closing the gap between Hims's category-leading top-three rate and its rank-one rate.

Why This Matters

Hims already reaches the buyer shortlist more often than any other brand in the category. The gap is what happens after the shortlist forms. Rogaine reaches the same shortlist at nearly the same rate and is chosen first twice as often. In a category where AI systems are increasingly the first place buyers ask for a recommendation, that difference decides which brand gets considered and which brand gets chosen.

Presence alone is not the constraint for Hims. The brand appears in 71.78% of qualified observations and holds the highest top-three rate in the category. The next move is targeted correction of the prompt, page, and citation layers that determine first position, starting with the platforms where Hims already has strong coverage and the comparison questions where Rogaine currently wins.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Hims in October 2026: (285 × 1 + 94 × 0 + 0 × -1) / 379 = 0.7520.

This matters because unclassified mention counts are misleading. A brand can appear in hundreds of AI answers and still lose the recommendation if most of those appearances are neutral references, comparison anchors, or cautionary framing. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal, and counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, because it separates brands that are being chosen from brands that are merely being named.

Hims carries no negative mentions in the October 2026 qualified set, which means the brand's framing problem is not reputational. The gap is placement, not perception.

Sentiment by Platform

Questions This Section Answers

• Which AI platforms give Hims the strongest sentiment framing?
• Where does Hims appear as context rather than as a recommendation?

Methodology

1. This report is a benchmark-based AI Visibility Company Market Strategy Report for Hims in the Hair Loss Treatments category, produced from the LLM Authority Index AI Visibility Market Discovery Index and the associated company-level metrics aggregation for October 2026.
2. The reporting window is October 2026, with baseline comparisons drawn from July 2026 where the benchmark provides them.
3. Six AI and search surfaces were tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode. All six produced at least one qualified observation in October 2026.
4. The October 2026 run began with 800 source prompt-surface observations, covering 651 unique questions. Of those, 698 were relevant to the category and 102 were off-topic, producing 528 qualified observations that serve as the public denominator for all brand-level percentages.
5. The competitor universe contains 10 tracked brands: Bosley, Folexin, HairClub, Happy Head, Hims, Keeps, Nutrafol, Propecia (Merck), Ro, and Rogaine.
6. One public high-intent cluster reached sufficient coverage in October 2026: Best Hair Loss Treatments & Top Solutions, a consideration-stage cluster. The Hair Loss Treatment Comparisons and Hair Loss Treatment Pricing & Cost clusters produced no qualified observations and are not part of the public series this month.
7. Stage 0 extraction retains the query, AI or search surface, answer, brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources for each observation.
8. A mention is counted when a tracked brand appears anywhere in an AI answer within a qualified observation, whether or not the answer recommends it.
9. A valid recommendation is counted when a tracked brand appears in a recommendation that meets benchmark criteria, including placement and framing conditions. Neutral references, comparison anchors, and listed-only appearances do not receive valid recommendation credit.
10. Top-three rate and rank-one rate are calculated against the 528 qualified observations, not against the brand's own mention count. Average recommended rank covers rank-eligible recommendations only.
11. The benchmark treats month-over-month movement within a defined range as normal variation. Movements outside that range are classified as significant. The benchmark identifies changes worth investigating; it does not establish what caused them.
12. The public benchmark does not measure market share, attributable sales, every possible AI response, organic-search ranking, social mention volume, private or sponsored channels, or causality from a metric movement alone. Source presence in the citation layer is evidence about the information environment and is not automatically proof that a source caused a recommendation.

See How AI Is Recommending Your Brand

The public benchmark shows where Hims stands in AI-generated hair loss treatment recommendations. A company-level AI visibility audit shows which prompts drive the rank-one placements Hims is missing, which competitors take the first position when Hims appears in the shortlist, and which owned pages and external sources shape those answers. The audit maps prompt, platform, competitor, placement, sentiment, and citation patterns into a prioritized visibility plan built on the same measurement framework used in this benchmark.